Cellular dynamics in germinal centers during vaccination
Cellular dynamics in germinal centers during vaccination
批准号:
8588282
负责人:
Michel C Nussenzweig
金额:
$41.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-12-01 至 2016-11-30
关键词:
AddressAffinityAgonistAnatomyAntibody AffinityAntigen PresentationAntigen-Presenting CellsAntigensB-LymphocytesBehaviorBiochemical GeneticsBlast CellCD28 geneCD4 Positive T LymphocytesCell CommunicationCell SeparationCell membraneCellsCellular StructuresCuesDataEventFollicular Dendritic CellsFundingFutureGenerationsGrantGreen Fluorescent ProteinsHIVHelper-Inducer T-LymphocyteHost DefenseImageImmigrationImmunoglobulin Class SwitchingImmunologyIn VitroIntercellular JunctionsInvadedLaser Scanning MicroscopyLeftLightLocationMediatingMembraneModelingMovementMusNatural HistoryNaturePeptide/MHC ComplexPhenotypePlasmaPlasma CellsProcessProteinsPublic HealthReactionReagentReceptor SignalingRegulationResearchRoleSeriesShapesSignal TransductionSiteSomatic MutationStagingStructureStructure of germinal center of lymph nodeSumSynaptic CleftT-Cell ActivationT-Cell ReceptorT-LymphocyteTNFRSF5 geneTSG101 geneTestingTimeTissuesTransgenic MiceTravelVaccinatedVaccinationVaccine DesignVaccinesautoreactive B cellbaseextracellularimmunological synapsein vivoinsightinterestintravital microscopylymph nodesmigrationnanoscalenovelpathogenplasma cell differentiationpublic health relevancereceptorresponsesuccesstwo-photonuptakevaccination strategy
中文摘要
描述(由申请人提供):产生适当同种类型的高亲和力抗体对于宿主抵抗细胞外病原体和大多数疫苗的成功是必不可少的。生发中心既是亲和力成熟的场所,也是T细胞依赖的类别转换的场所。在之前的资助期间,我们进行了一系列活体显微镜研究,揭示了生发中心功能的新方面。结果表明:1)生发中心是动态开放的结构,生发中心B细胞在明暗区之间迁移;2)明暗区细胞具有相似的形状、大小和行为;3)幼稚的B细胞可以通过生发中心迁移;4)生发中心可以随时被高亲和力的B细胞侵袭;5)血浆母细胞在从滤泡向髓索移动的过程中,在淋巴结内显示了一种新的迁移方式--“随机冲刺”,这是在没有特定趋化信号的情况下在组织中的间隔之间移动的最佳方式;6)生发中心带间迁移的循环再入模型是正确的,光明区到暗区的迁移是由T细胞帮助控制的。在这项建议中,我们提出了两个新的目标,重点是T细胞在控制早期选择事件中的作用,以及滤泡辅助T细胞如何与生发中心B细胞通信。我们假设:1)B细胞之间基于亲和力的竞争发生在生发中心反应之前;2)T细胞抑制自身反应性B细胞的出现;3)T细胞通过TCR阳性微泡与B细胞沟通,这些微泡通过动态细胞-细胞连接或Kinapse转移。我们将通过两个特定的目标来验证这些假说:1)表征生发中心亲和力竞争和T细胞介导的生发中心B细胞耐受性的调节;2)确定微囊在体内外T细胞与GC B细胞通讯中的作用。我们预计,这些研究将解决这些假设的有效性,并对未来疫苗的设计方式产生影响。
英文摘要
DESCRIPTION (provided by applicant): Generation of high affinity antibodies of the appropriate isotype is essential for host defense against extracellular pathogens and for the success of most vaccines. Germinal centers are the sites of both affinity maturation and T cell dependent class switching take. In the previous funding period we performed a series of intravital microscopy studies that revealed novel aspects of germinal center function. We demonstrated that 1) germinal centers are dynamic open structures and that germinal centers B cells migrate between light and dark zones; 2) light and dark zone cells display similar shape size and behavior; 3) naive B cells can migrate through germinal centers; 4) germinal centers can be invaded at any time by higher affinity B cells; 5) plasma blasts display a novel mode of migration in lymph nodes in moving from the follicle to the medullulary cords- a "random sprint" which is the best way to travel between compartments in a tissue without specific chemotactic cues; 6) that the cyclic reentry model for interzonal migration in germinal centers is correct and that light zone to dark zone migration is controlled by T cell help. In this proposal we propose two new Aims focusing on the role of T cells in controlling early selection events and how follicular helper T cells communicate with germinal center B cells. We hypothesize that 1) affinity based competition between B cells takes place prior to the germinal center reaction; 2) that T cells suppress the emergence of autoreactive B cells and 3) that T cells communicate with B cells through TCR positive microvesicles that are transferred through a dynamic cell-cell junction, or kinapse. We will test these hypotheses through 2 specific Aims: 1) to characterize germinal center affinity competition and T cell mediated regulation of B cell tolerance in the germinal center; and 2) to determine the role of microvesicles in T cell communication with GC B cells in vitro and in vivo. We anticipate that these studies will address the validity of these hypotheses and have an impact on the way that vaccines are designed in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10841240
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10327992
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10221136
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10221139
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10546453
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:9546037
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10331863
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10454947
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10454946
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10540735
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10300443
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:9982204
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
-
批准号:10265634
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10454949
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:9569038
-
项目类别:
-
资助金额:$136.51万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10062819
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:9982202
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10216965
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10216964
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10216967
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
海外基金